EDTA (ethylene di-amine tetra-acetic acid) is a metal chelator, and is used to detoxify from heavy metals such as mercury, lead and cadmium.
Liposomal EDTA with R-Lipoic Acid is a highly absorbable liposomal form of oral EDTA, delivered with the antioxidant R-lipoic acid (as sodium R-lipoate), that supports endogenous production of glutathione, an integral component of detoxification, as well as metal mobilization and recovery.
Quicksilver Scientific utilizes sodium R-lipoate for this formula as higher plasma levels of lipoic acid have been shown to be achievable when supplemented in the sodium salt form.
Lipoic acid has been shown to extend the biological activity of vitamins C and E, also raising ubiquinol (commonly known as CoQ10) levels and endogenous production of glutathione via the Nrf2 nuclear transcription pathway.
Lipoic acid has evidence as a chelator of redox-active metals in vitro and in vivo.
Lipoic acid has been shown to cross the blood-brain barrier, which is why it also has been shown to have neuroprotective actions.
Optimized bioavailability of EDTA and R-Lipoate is with liposomes. The essential phospholipids delivered in this format nourish the membranes of the cells, ensuring proper function for the absorption of nutrients and the excretion of cellular waste products and toxins.
Very small liposomes are rapidly absorbed orally and through lymphatics, and allows intracellular delivery of their encapsulated contents, leading to higher intracellular delivery than possible with intravenous (IV) therapies.